
Bara Vaida is an experienced journalist who reported on business, consumer, wellness, and policy issues before joining the Institute in August 2023. As the director of training, Vaida is developing and expanding the Institute’s professional development portfolio and training strategy; creating unique learning opportunities for journalists; and producing timely resources for journalists, including the Institute’s afternoon newsletter, The Latest. Through her 30 years as both a newsroom and independent journalist, Vaida has navigated the halls of Congress and has gained an in-depth understanding of corporate, economic, and international business issues, health care policy, lobbying, and technology. She has worked for some of Washington’s biggest news organizations, including National Journal, Agence France-Presse, and Bloomberg News and has been a guest on numerous radio and television shows, including, C-SPAN’s Washington Journal, Washington Week with Gwen Ifill, and WAMU’s Kojo Nnamdi show. In 2020, at the height of the coronavirus pandemic, Vaida served as the core topic leader on infectious diseases for the Association of Health Care Journalists. In that role, she coordinated training and resources to assist her peers as they reported in real time the ongoing health crisis.
By forcing the Food and Drug Administration on Aug. 23 to approve blood plasma as a COVID-19 treatment under an…
To showcase how schools could reopen safely this year, Centers for Disease Control and Prevention director Robert Redfield, M.D., highlighted…
As we start moving into fall and winter, Americans are certain to be facing a continuation of COVID-19, the disease…
Communities and school leaders need to exercise common sense as they weigh options for reopening schools this fall, said Anthony…
As school leaders and parents grapple with questions about school reopening this fall, a key measure to consider is the…
A little-reported side effect of surging COVID-19 cases is the likelihood that there will be an increasing number of people…
America’s 13,000 school systems have been under tremendous pressure to reopen in-person classes this fall but are struggling with how…
The National Institutes of Health last month halted a clinical trial of hydroxychloroquine for use in treating COVID-19 patients. The…
Scientists now have a much better idea of how people become infected with SARS-CoV-2, the virus that causes COVID-19. But…
As businesses and communities across the country reopen, many Americans continue to have questions about how they can interact safely…